Stock Taper
Waldencast Acquisition Corp. offers advanced dermatologist- and professional-distributed skincare products, including Obagi and Obagi Clinical, to reduce signs of aging, damage, hyperpigmentation, and sun exposure.

Waldencast's FDA-approved hyaluronic acid dermal filler, launched under the Obagi Medical brand, targets moderate to severe facial wrinkles, marking its entry into the U.S. medical aesthetics market.
| Icon | PRODUCT | Q4-2022 |
|---|---|---|
![]() | Product | $90.39M |
![]() | Royalty | $1.99M |
| Map | REGION | Q4-2022 |
|---|---|---|
![]() | UNITED STATES | $54.3M |
![]() | CHINA | $17M |
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
APCX | $0.36 | COMPARE |
BIYA | $2.23 | COMPARE |
AUUD | $0.97 | COMPARE |
OLB | $0.31 | COMPARE |
BOXL | $5.95 | COMPARE |
MASK | $1.39 | COMPARE |
MYSZ | $2.60 | COMPARE |